Rajabnia Mohsen, Sadeghi Amir, Abdi Saeed, Găman Mihnea-Alexandru, Zali Mohammad Reza, Salehi Niloufar, Yadegar Abbas, Rahmani Khaled
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Science, Tehran, Iran.
Carol Davila University of Medicine and Pharmacy, Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
GE Port J Gastroenterol. 2021 Sep 6;29(5):322-330. doi: 10.1159/000518597. eCollection 2022 Sep.
Statins have been used as adjuvants to standard treatment in order to increase the eradication rates of infection. This study aimed to summarize the results of the efficacy of adding statins to standard treatments used for the eradication of infection. We conducted a systematic search using a comprehensive combination of keywords in PubMed/MEDLINE, Web of Science, and Scopus to retrieve relevant studies from 1990 to 2020. The estimate of pooled relative risk (RR), as the effect measure, was calculated using random effects meta-analyses in Stata 14. We finally included 5 studies (all of them were randomized controlled trials). The meta-analysis of all studies showed that the pooled RR (95% confidence interval) was 1.03 (0.64-1.68) in the random effects model, which was not statistically significant. In other words, based on our meta-analysis, the addition of statins as an adjuvant therapy to the standard treatment regimens does not increase the rate of eradication. However, further evidence is needed to confirm this result as the number of available studies was small.
他汀类药物已被用作标准治疗的辅助药物,以提高感染的根除率。本研究旨在总结在用于根除感染的标准治疗中添加他汀类药物的疗效结果。我们在PubMed/MEDLINE、科学网和Scopus中使用综合关键词组合进行系统检索,以检索1990年至2020年的相关研究。作为效应量的合并相对风险(RR)估计值,使用Stata 14中的随机效应荟萃分析进行计算。我们最终纳入了5项研究(所有研究均为随机对照试验)。所有研究的荟萃分析表明,在随机效应模型中,合并RR(95%置信区间)为1.03(0.64 - 1.68),无统计学意义。换句话说,根据我们的荟萃分析,在标准治疗方案中添加他汀类药物作为辅助治疗并不能提高根除率。然而,由于现有研究数量较少,需要进一步的证据来证实这一结果。